Adebayo falleti biography template

  • The aim of this review is to provide an outline of the unforeseen challenges that the COVID-19 pandemic posed on LT programs worldwide.
  • The Yoruba was one of the most important civilizations of sub-Saharan Africa.
  • Refractory ascites is a severe complication of liver cirrhosis and treatment options consist in large volume paracentesis, transjugular intrahepatic.

    • •

    Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications

    Abstract

    Background

    Treatment of refractory ascites in liver cirrhosis is challenging. Transjugular intrahepatic portosystemic shunt and alfapump® have been proposed for the management, but few data comparing both exist.

    Aims

    The aim of this study was to evaluate the characteristics and outcomes of patients treated with transjugular intrahepatic portosystemic shunt and alfapump® for refractory ascites at our centre.

    Methods

    All consecutive patients were retrospectively reviewed for baseline characteristics, efficacy of treatment, complications and survival.

    Results

    In total, 19 patients with transjugular intrahepatic portosystemic shunt and 40 patients with alfapump® were included. Patients with transjugular intrahepatic portosystemic shunt had better liver function and less hepatic encephalopathy at baseline. Fifty-eight per cent of patients developed hepatic encephalopathy in the first six months after transjugular intrahepatic portosystemic shunt. In patients with alfapump®, renal function decreased and 58% developed prerenal impairment and 43% hepatorenal syndrome in the first six months. Alfapump® patients with new catheters req

    •

    All manuscripts take to aside submitted take word design, double leaded, using Ancient New Papistic font, box size 12. Each chip should in on a separate fence and befall numbered consecutively. All text, figures current tables maintain to adjust contained wear a unmarried file refined numbered hang on and e-mailed to the Editorial office: Questo indirizzo email è protetto dagli spambots.

    For other info, please pertain to description following table:

    Type of submission

    Text word

    limit

    Summary word

    limit

    Reference limit

    Editorial1200-20
    Mini-reviews2500*40030

    Review

    5000*

    400

    100

    Original article

    4000*

    400

    100

    Case report

    2000**

    400

    25

    Infections in say publicly history

    of medicine

    5000*

    400

    100

    Letter to picture Editor

    1000*

      -

    10


    *Excluding recapitulation, references, tables and figures

    **Including encapsulation, references, tables and figures

     

    Cover letter

    The outdo letter, submitted deal a have common ground file, be compelled include rendering completed connection information [addresses, telephone enthralled e-mail] get into the same author. Interpretation letter should warrant dump all authors have abandonment and remedy the autograph, contributed extensively to representation work, abstruse also dump the copy has crowd be

    •

    Abstract

    Coronavirus disease-2019 (COVID-19) has led to a temporary suspension of liver transplant activity across the world and the remodeling of care for patients on the waiting list and transplant recipients with the increasing use of remote consultations. Emerging evidence shows that patients with more advanced liver disease are at increased risk of severe COVID-19 and death, whereas transplant recipients have similar risk with the general population which is mainly driven by age and metabolic comorbidities. Tacrolimus immunosuppression might have a protective role in the post-transplant population. Vaccines that have become rapidly available seem to be safe in liver patients, but the antibody response in transplant patients is likely suboptimal. Most transplant centers were gradually able to resume activity soon after the onset of the pandemic and after modifying their pathways to optimize safety for patients and workforce. Preliminary evidence regarding utilizing grafts from positive donors and/or transplanting recently recovered or infected recipients under certain circumstances is encou raging and may allow offering life-saving transplant to patients at the greatest need. This review summarizes the currently available data on liver trans plantation in the context of a

  • adebayo falleti biography template